NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

Very thoughtful. Now consider this. The cancer that NWBO initially went after was an "Orphan" ie. RARE. Even so the addressable is multi Billions USD. In GBM there are no current BP add on drugs to SOC as in drugs like Keytruda.
Next up for DCVax will undoubtably be a MAJOR Cancer of high incidence as in Breast, Lung, Colon, Protate, Ovarian. DCVax-L or Direct in combo with a BP add on to SOC in one of these much more prevalent and geometrically larger USD markets and yet "Easier to Treat" in some instances Cancer Indications MIGHT LEAD to outstanding shocking effacacy.
To those that are chagrined at the seamingly perplexing lack on market appreiciation for NWBO on milestones might be surprized at the Market ground swells that erupt on good trial results in one of these Major Cancers even in mid stage trials.
Hold your seats the show is just getting started.